The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation

International Journal of Cardiology

Volumn 164, Issue 1, 2013, Pages 94-98

  Letsas, Konstantinos P ^a,b   Siklódy, Claudia Herrera ^b   Korantzopoulos, Panagiotis ^c   Weber, Reinhold ^b   Bürkle, Gerd ^b   Mihas, Constantinos C ^a   Kalusche, Dietrich ^b   Arentz, Thomas ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Atrial fibrillation; Catheter ablation; Inflammation; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; URIC ACID;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART VENTRICLE SIZE; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; LEFT VENTRICULAR END DIASTOLIC DIAMETER; LEFT VENTRICULAR END SYSTOLIC DIAMETER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT CODING; PATIENT SAFETY; PERSISTENT HEART ATRIUM FIBRILLATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIATION EXPOSURE; RECURRENCE RISK; REFERENCE VALUE; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVERSION; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FLUOROSCOPY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; MIDDLE AGED; PROBABILITY; SINUS RHYTHM;

ATRIAL FIBRILLATION; BODY MASS INDEX; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84875222894     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.092     Document Type: Article

References (28)

1. J. Wärnberg, E. Nova, and L.A. Moreno AVENA Study Group. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA study Am J Clin Nutr 84 2006 505 512
2. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 2002 359 364
3. C.J. Boos, R.A. Anderson, and G.Y. Lip Is atrial fibrillation an inflammatory disorder? Eur Heart J 27 2006 136 149
4. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
5. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021-2018.
6. T. Liu, G. Li, L. Li, and P. Korantzopoulos Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis J Am Coll Cardiol 49 2007 1642 1648
7. K.P. Letsas, R. Weber, and G. Bürkle Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation Europace. 11 2009 158 163
8. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 2007 135 143
9. T.J. Wang, H. Parise, and D. Levy Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477
10. L. Frost, L.J. Hune, and P. Vestergaard Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study Am J Med 118 2005 489 495
11. U.B. Tedrow, D. Conen, and P.M. Ridker The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study) J Am Coll Cardiol 55 2010 2319 2327
12. N. Wanahita, F.H. Messerli, S. Bangalore, A.S. Gami, V.K. Somers, and J.S. Steinberg Atrial fibrillation and obesity-results of a meta-analysis Am Heart J 155 2008 310 315
13. K. Chilukuri, D. Dalal, and S. Gadrey A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation J Cardiovasc Electrophysiol 21 2010 521 525
14. K. Jongnarangsin, A. Chugh, and E. Good Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation J Cardiovasc Electrophysiol 19 2008 668 672
15. Y.M. Cha, P.A. Friedman, and S.J. Asirvatham Catheter ablation for atrial fibrillation in patients with obesity Circulation 117 2008 2583 2590
16. D. Patel, P. Mohanty, and L. Di Biase Outcomes and complications of catheter ablation for atrial fibrillation in females Heart Rhythm 7 2010 167 172
17. V. Fuster, L.E. Rydén, and D.S. Cannom 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 123 2011 e269 e367
18. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
19. National Heart Lung and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD 1998 NIH publication no. 98-4083.
20. T. Arentz, R. Weber, and G. Bürkle Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study Circulation 115 2007 3057 3063
21. J.A. Dempsey, S.C. Veasey, B.J. Morgan, and C.P. O'Donnell Pathophysiology of sleep apnea Physiol Rev 90 2010 47 112
22. K. Todd, W.F. McIntyre, and A. Baranchuk Obstructive sleep apnea and atrial fibrillation Nat Sci Sleep 2 2010 39 45
23. D. Patel, P. Mohanty, and L. Di Biase Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure Circ Arrhythm Electrophysiol 3 2010 445 451
24. K.M. Rexrode, A. Pradhan, J.E. Manson, J.E. Buring, and P.M. Ridker Relationship of total and abdominal adiposity with CRP and IL-6 in women Ann Epidemiol 13 2003 674 682
25. K. Esposito, A. Pontillo, and C. Di Palo Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial JAMA 289 2003 1799 1804
26. J. Ector, O. Dragusin, and B. Adriaenssens Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation J Am Coll Cardiol 50 2007 234 242
27. J.D. Ferguson, A. Helms, and J.M. Mangrum Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping Circ Arrhythm Electrophysiol 2 2009 611 619
28. V.Y. Reddy, G. Morales, and H. Ahmed Catheter ablation of atrial fibrillation without the use of fluoroscopy Heart Rhythm 7 2010 1644 1653